Search the GHTC website

Global health R&D delivers for North Dakota

US government investment in global health R&D has delivered

$647 thousand
to North Dakota research institutions
Global health R&D at work in North Dakota

Researchers at the University of North Dakota are studying whether the presence of a parasite in a person’s blood enhances the transmission of Zika. Nematodes are parasitic roundworms that are common in Latin America and the Caribbean, and there is some indication that nematodes may enhance viral transmission. If they have this effect, the discovery could lead to new approaches to combat the Zika virus. Zika, which is spread by mosquitoes, can be transferred from a pregnant woman to her unborn child, causing devastating birth defects. There is no vaccine to prevent infection with Zika nor medicine to cure it. With global travel, this public health threat is not isolated to one part of the world. Addressing Zika and finding a cure is about protecting women, families, and communities everywhere.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Case study photo: Pan American Health Organization